Skip to Content
American Heart Association
Sign-in / Sign-up
Join or Renew
My Local Events
Find out what is happening at your local American Heart
Have an account?
Need an account?
Login with Your Social Identity:
Statements & Guidelines
FDA approves evolocumab, a PCSK9 inhibitor, to treat certain patients with high cholesterol
The Impact of Prevention on Reducing the Burden of CVD (using Archimedes model)
The Impact of Prevention on Reducing the Burden of CVD (using Archimedes model) - A joint paper by AHA/ADA/ACS
The most cost-effective strategies for preventing cardiovascular disease.
Scope and impact of prevention on morbidity, mortality and direct medical costs.
Life-years which can be gained from engaging in prevention activities.
Read full article in
Top Ten Things to Know
ACS/ADA/AHA Scientific Statement: Preventing Cancer, Cardiovascular Disease, and Diabete
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
Become A Member
Join or renew your AHA/ASA Professional Membership
to qualify for members-only awards, and:
• Affiliate with one of 16 Scientific Councils.
• Save on AHA/ASA Scientific Sessions.
• Save on print publications.
• Apply for research funding and not pay a fee
many more membership benefits
Promo code: WDJ008ZZ